GF Fund Management’s Verona Pharma VRNA Stock Holding History

GF Fund Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,826	Closed	-$195K	–	698
2025 Q3	$195K	Sell	1,826 -68	-4%	-$7.1K	﹤0.01%	294
2025 Q2	$179K	Sell	1,894 -7,870	-81%	-$583K	﹤0.01%	327
2025 Q1	$620K	Buy	9,764 +8,211	+529%	+$491K	0.01%	225
2024 Q4	$72.1K	Buy	+1,553	New	+$58.3K	﹤0.01%	359

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GF Fund Management's VRNA Position: Q4 2025 in Review

GF Fund Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 1,826 shares — an estimated $195K sold.

GF Fund Management first reported a position in VRNA in Q4 2024 and held it in 4 quarters. The position peaked at $620K in Q1 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

GF Fund Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
GF Fund Management sold 1,826 Verona Pharma shares in Q4 2025, an estimated $195K.
GF Fund Management first reported a position in Verona Pharma in Q4 2024 and held it in 4 quarters.
GF Fund Management's Verona Pharma position peaked at $620K in Q1 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on GF Fund Management's 13F filing for Q4 2025, filed 27 Jan 2026.